Affiliation:
1. Laboratory of Pharmacology and Pharmacognosy, Faculty of Pharmacy, University of Barcelona, Zona Univ. Pedralbes, 08028 Barcelona (BCN), Spain
Abstract
Abstract
The peripheral adrenergic effects of orphenadrine, an antiparkinsonian drug, have been evaluated in the rat vas deferens to investigate whether these properties are the same as those of other phencyclidine ligands.
In the low micromolar range, orphenadrine enhanced electrically-evoked and exogenous noradrenaline contractile responses in the epididymal portion of rat vas deferens. It also induced spontaneous activity that was inhibited by prazosin (1 μM) but not by atropine (20 nM). It inhibited accumulation of [3H]noradrenaline in rat vas deferens (IC50 = 14.2 ± 2.3 μM). Orphenadrine competitively inhibited [3H]nisoxetine binding in rat vas deferens membranes (Ki = 1.05 ± 0.20 μM).
It can be concluded that orphenadrine, at low micromolar concentrations, interacts with the noradrenaline reuptake system inhibiting its functionality and thus potentiating the effect of noradrenaline.
Publisher
Oxford University Press (OUP)
Subject
Pharmaceutical Science,Pharmacology
Reference21 articles.
1. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol;Altamura;Acta Neurol. Napoli,1986
2. Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa;Bassi;Br. J. Clin. Pract.,1986
3. A rapid sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976
4. Simple and rapid GLC method for the determination of orphenadrine in human plasma;Contin;Biomed. Chromatogr.,1987
5. Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats? Case of amantadine and memantine;Danysz;J. Neural. Transm. [PD Sect.],1994
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献